Shanhang Li

Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Pulmonary metastasectomy and survival in osteosarcoma: a systematic review and meta-analysis of surgery-related prognostic factors.

Pulmonary metastasectomy and survival in osteosarcoma: a systematic review and meta-analysis of surgery-related prognostic factors.

Journal: World journal of surgical oncology

Published: February 13, 2026

Formononetin Antagonizes Osteosarcoma Metastasis by Targeting CD44: An Integrated Multi-Omics Study.

Formononetin Antagonizes Osteosarcoma Metastasis by Targeting CD44: An Integrated Multi-Omics Study.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 23, 2025

Molecular characterization and prognostic modeling of liquid-liquid phase separation-related genes in osteosarcoma based on single-cell sequencing and weighted gene co-expression network analysis.

Molecular characterization and prognostic modeling of liquid-liquid phase separation-related genes in osteosarcoma based on single-cell sequencing and weighted gene co-expression network analysis.

Journal: Translational cancer research

Published: June 26, 2025

Formononetin suppresses osteosarcoma by targeting MYO1B and remodeling the tumor immune microenvironment.

Formononetin suppresses osteosarcoma by targeting MYO1B and remodeling the tumor immune microenvironment.

Journal: APL bioengineering

Published: June 05, 2025

Pan-cancer analysis reveals TREM1+ PMN-MDSCs as critical regulators of immune suppression and tumor microenvironment remodeling.

Pan-cancer analysis reveals TREM1+ PMN-MDSCs as critical regulators of immune suppression and tumor microenvironment remodeling.

Journal: Communications biology

Published: April 10, 2025

Single-cell RNA and bulk sequencing analysis reveals that formononetin inhibits GTSF1 to exert anti-osteosarcoma effects.

Single-cell RNA and bulk sequencing analysis reveals that formononetin inhibits GTSF1 to exert anti-osteosarcoma effects.

Journal: APL bioengineering

Published: February 20, 2025

Formononetin enhances cisplatin chemotherapy sensitivity in osteosarcoma by inducing ferroptosis and reconstructing the immune microenvironment.

Formononetin enhances cisplatin chemotherapy sensitivity in osteosarcoma by inducing ferroptosis and reconstructing the immune microenvironment.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 08, 2024

Single-Cell RNA Sequencing Reveals the Critical Role of SEC16B in Lung Metastasis of Osteosarcoma.

Single-Cell RNA Sequencing Reveals the Critical Role of SEC16B in Lung Metastasis of Osteosarcoma.

Journal: FASEB bioAdvances

Published: September 21, 2024

Prognostic significance of T cells and NK cells in osteosarcoma: a dual-center retrospective study.

Prognostic significance of T cells and NK cells in osteosarcoma: a dual-center retrospective study.

Journal: World journal of surgical oncology

Published: August 13, 2024

Showing 1-9 of 9

Last Updated: 09/26/2026